新聞報導於大約1年前
三星已開始預告新款螢幕可凹折手機，並在印度網站放上型號為SM-F956B/DS的產品技術支援頁面，預示即將推出的Galaxy Z Fold6。除了Fold6，預期也會推出直向凹折Galaxy Z Flip6，搭載Qualcomm Snapdragon 8 Gen 3處理器。Fold6設計有外部6.3吋和內部7.6吋Dynamic AMOLED 2x顯示螢幕，支援120Hz畫面更新率和S Pen手寫輸入，配置12GB RAM和1TB儲存。另推出可能更高階的Galaxy Z Fold6 Ultra和Galaxy Z Flip6，以及新款Galaxy Watch智慧手錶和Galaxy Ring智慧戒指。
小見聞來源: YAHOO
新聞報導於大約1年前
Eli Lilly's drug tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight loss, has the potential to target the non-alcoholic steatohepatitis (NASH) market, a field with a significant unmet need as the first NASH medicine in the U.S. was just approved this year. Tirzepatide showed promising results in phase 2 studies, sparking hope for future success in treating NASH. While the NASH market is competitive, Eli Lilly's overall pipeline and revenue growth suggest a positive outlook for the company, with analysts predicting substantial earnings growth annually and strong potential for investment.
小見聞來源: YAHOO